Stock 300357 ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Equities

300357

CNE100001R58

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
23.26 CNY -0.04% Intraday chart for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. +2.92% -19.79%
Apr. 18 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Business Summary

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of bio-pharmaceutical products. The Company's main products include Dermatophagoides Farinae Drops and Dermatophagoides Farinae Skin Prick Diagnostic Kits. The Company's products are primarily used for the treatment of allergic rhinitis caused by dust mite allergy, the desensitization of allergic asthma and the in-vivo diagnosis of dust mite drops. The Company distributes its products in domestic market.

Number of employees: 1,709

Sales per Business

CNY in Million2022Weight2023Weight Delta
Dust Mite Drops
96.8 %
879 98.1 % 821 96.8 % -6.60%
Artemisia Annua Pollen Allergen Sublingual Drops
1.8 %
8 0.9 % 15 1.8 % +84.32%
Research and Development Services
0.6 %
4 0.4 % 5 0.6 % +28.80%
Skin Prick Diagnosis Kit
0.4 %
- - 4 0.4 % -
Rental
0.3 %
- - 2 0.3 % -
Sensitivity Test Needle
0.1 %
- - 1 0.1 % -
Cosmetic
0.0 %
- - 0 0.0 % -
Others
0.0 %
- - 0 0.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
896 100.0 % 848 100.0 % -5.34%

Managers

Managers TitleAgeSince
Geng Xi Hu CEO
 Chief Executive Officer 60 02-09-18
Guo Qi Wang DFI
 Director of Finance/CFO 50 16-04-05
Tao Jin CHM
 Chairman 38 12-07-31
Long Ji BRD
 Director/Board Member 36 12-12-31
Zi Qiang Bi BRD
 Director/Board Member 60 16-10-25
Hui Feng Yang BRD
 Director/Board Member 30 15-06-30
Zhen Wei Guan SEC
 Corporate Secretary 43 20-09-10
Lu Zhang BRD
 Director/Board Member 45 11-01-27

Members of the board

Members of the board TitleAgeSince
Geng Xi Hu CEO
 Chief Executive Officer 60 02-09-18
Ni Chen Yan BRD
 Director/Board Member 59 11-01-27
Lu Zhang BRD
 Director/Board Member 45 11-01-27
Tao Jin CHM
 Chairman 38 12-07-31
Hui Feng Yang BRD
 Director/Board Member 30 15-06-30
Guo Liang Xu BRD
 Director/Board Member 59 20-06-01
Zi Qiang Bi BRD
 Director/Board Member 60 16-10-25
Fei Da Zhang BRD
 Director/Board Member 44 22-12-27
Long Ji BRD
 Director/Board Member 36 12-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 523,584,000 261,296,773 ( 49.91 %) 0 49.91 %

Shareholders

NameEquities%Valuation
Zhejiang Wowu Management Consulting Co. Ltd.
44.46 %
203,454,131 44.46 % 640 M ¥
China International Capital Corp. Ltd. (Invt Management)
4.568 %
20,903,887 4.568 % 66 M ¥
Harvest Fund Management Co., Ltd.
3.636 %
16,639,439 3.636 % 52 M ¥
GF Fund Management Co., Ltd.
2.430 %
11,120,292 2.430 % 35 M ¥
Geng Xi Hu
2.387 %
10,924,593 2.387 % 34 M ¥
Li Hong Wang
1.342 %
6,140,035 1.342 % 19 M ¥
Fullgoal Fund Management Co., Ltd.
1.198 %
5,482,602 1.198 % 17 M ¥
China Merchants Fund Management Co., Ltd.
1.180 %
5,398,959 1.180 % 17 M ¥
Zhong Ou Asset Management Co., Ltd
0.8965 %
4,102,085 0.8965 % 13 M ¥
China Southern Asset Management Co., Ltd.
0.5931 %
2,713,888 0.5931 % 9 M ¥
NameEquities%Valuation
Geng Xi Hu
62.67 %
32,773,777 62.67 % 103 M ¥
Jian Hui Chen
10.32 %
5,396,018 10.32 % 17 M ¥
Lu Zhang
2.582 %
1,350,000 2.582 % 4 M ¥

Company contact information

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

636, Zhiyuan North Road Wukang Town

313200, Huzhou

+86 57 2883 1088

http://www.wolwobiotech.com
address Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.(300357)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
23.26 CNY
Average target price
29 CNY
Spread / Average Target
+24.68%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD. Stock Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
-19.79% 1.68B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.61% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.87% 570B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 321B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 300B
ASTRAZENECA PLC Stock AstraZeneca PLC
+7.09% 217B
ROCHE HOLDING AG Stock Roche Holding AG
-9.12% 204B
NOVARTIS AG Stock Novartis AG
+5.01% 199B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300357 Stock
  4. Company Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.